Juan Manuel T.
- Country
- Spain
- Department
- Infectious diseases service
Research Overview
- Evaluation of the Impact of a Broadly Neutralizing Antibody and Attachment Inhibitor on Viral Reservoirs in HIV Patients on Integrase Inhibitor-Based Antiretroviral Therapy
- Evaluation of Antiviral Efficacy and Safety of GSK4004280 and GSK4011499 in Treatment-Naïve Adults with HIV-1 Infection
- Evaluation of Doravirine on Hepatic Steatosis and Fibrosis in Asymptomatic HIV Patients: A Pilot Study
Data & Insights
Has run more than one trial at 16 of 64 partner sites.
Specializations
HIV Treatment Innovation
The investigator specializes in evaluating novel therapeutic approaches for HIV-1 infection, with particular emphasis on dual therapy regimens and treatment optimization strategies.
- Antiretroviral combination assessment
- Dual therapy optimization
- Treatment maintenance strategies
Primary focus includes investigating the efficacy of doravirine-based treatments and innovative antiretroviral combinations.
HIV Prevention Research
Conducts research in pre-exposure prophylaxis (PrEP) methodologies, specifically examining fixed-dose combination treatments for high-risk populations.
- PrEP efficacy studies
- Prevention strategies for at-risk groups
- Long-term prophylactic treatments
Particular attention to prevention strategies among men who have sex with men and transgender women.
HIV Comorbidity Management
Investigates the impact of HIV treatments on concurrent health conditions, with special interest in liver health management among people living with HIV.
- Liver steatosis assessment
- Fibrosis monitoring
- Metabolic outcomes evaluation
Focuses on the relationship between antiretroviral therapy and hepatic health indicators.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.